Igenomix Middle East +971 4 5519465

Product development

At IGENOMIX, we work in all the development phases of diagnostic tests: from the original concept, undertaking clinical studies, producing and analysing results, to their transfer to become products which can be commercialised. In the Products Development Department, we do not merely adapt already established procedures, but we innovate to provide our patients with the best services.

OBJECTIVES

  • Continually improving the procedures that are commercialised in the firm.
  • Transforming the knowledge generated in research projects into diagnosis products and personalised diagnosis methods.
  • Using genomics to develop new simpler, more complete, more accessible and, in particular, more personalised diagnosis methods.
  • Providing solutions for the requirements with which professionals are faced.

Reproductive genetics product development

PRODUCTS ON THE MARKET

Today, we offer a series of exclusive services for our customers which result from our R&D+I efforts.

ERA

Endometrial receptivity is the state in which the endometrium is in when it is ready for embryonic implantation to take place. This takes place in all menstrual cycles in fertile women at around day 21 of this cycle. Nowadays, the only study done on the endometrium is an ultrasound scan, and there is currently no analysis method available that helps doctors in their clinical practice.
Within the study of an infertile couple, the ERA (Endometrial Receptivity Array) analysis consists in assessing the woman’s endometrial receptivity status from the molecular viewpoint as an important analysis of the uterine factor. This molecular tool allows us to diagnose whether the endometrium is receptive or not by analysing the expression of a group of genes responsible for this function. To go about this, an endometrial biopsy must be done on day 21 of the menstrual cycle (the receptive phase) or on day LH+7, or after 5 days of progesterone in a substitute cycle.

CGI

The Genetic Identity Card (GIC) is a genetic fingerprint which is obtained from the individual’s DNA. Everyone’s DNA is unique and is the equivalent to our fingerprint. The GIC is indicated to genetically identify children born from donated gametes and/or adopted children.
Obtaining a GIC involves a simple collection of the child’s buccal cells using the cotton-wool swab supplied in the kit.